newsfilter
← Latest News
Business Wire·

Viridian Therapeutics Announces Proposed Underwritten Public Offering

Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that it has